Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Romidepsin by Bristol-Myers Squibb for Thyroid Cancer: Likelihood of Approval
Romidepsin is under clinical development by Bristol-Myers Squibb and currently in Phase I for Thyroid Cancer. According to GlobalData, Phase...
Romidepsin by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval
Romidepsin is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Romidepsin by Bristol-Myers Squibb for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
Romidepsin is under clinical development by Bristol-Myers Squibb and currently in Phase II for Anaplastic Large Cell Lymphoma (ALCL). According...